Otherwise, obesity-associated endocrine disorders in adipocytes can activate monocytes and subsequently trigger atherosclerosis, and adiponectin can inhibit this process through decreasing TLR4 expression on macrophage/monocytes. The gene discussed is TLR4; the disease is atherosclerosis.